Iridium Continuing Education

AML Without Borders: Advancing Care Through Collaborative Learning

Impact of PBC Treatment and ​Low Initiation Rates in PBC Therapy

Biomarkers, Pruritus Management, and Real-World Evidence​

AML Overview and ​Treatment Selection and Personalization

Targeted Therapies and ​Monitoring Strategies for AML

Worsening Heart Failure | Episode 4

Worsening Heart Failure | Episode 3

Worsening Heart Failure | Episode 2

Worsening Heart Failure | Episode 1

LDL-C Lowering in Women and People of Color | Episode One

LDL-C Lowering in Women and People of Color | Episode Two

Understanding COPD and Its Impact​

Personalized Strategies in COPD Management ​

Tackling Delayed Diagnosis and Treatment Escalation ​in COPD

Overview of Cystic Fibrosis and Recognizing Health Disparities in its Care

Staying Informed – ​Analyzing Cystic Fibrosis Treatment Advances

Staying Informed – ​Analyzing Cystic Fibrosis Treatment Advances

Overview of Cystic Fibrosis and Recognizing Health Disparities in its Care

Bridging Gaps in COPD Management: From Evidence to Practice ​

Tackling Delayed Diagnosis and Treatment Escalation ​in COPD

Understanding COPD and Its Impact​

Personalized Strategies in COPD Management ​

LDL-C Lowering in Women and People of Color | Episode Two

LDL-C Lowering in Women and People of Color | Episode One

Worsening Heart Failure | Episode Three

Worsening Heart Failure | Episode Four

Worsening Heart Failure | Episode Two

Worsening Heart Failure | Episode One

Targeted Therapies and ​Monitoring Strategies for AML

Biomarkers, Pruritus Management, and Real-World Evidence​ in PBC